Instrumentarium buys Spacelabs for $140 million
This article was originally published in Clinica
Finnish company Instrumentarium is to boost its presence in the US critical care monitoring market with its $140 million acquisition of Spacelabs Medical. Under the deal, which will be financed through cash and existing credit facilities, Instrumentarium will offer $14.25 per share in cash.
You may also be interested in...
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
The US Food and Drug Administration posted two device-related closeout letters in November.
Jazz and PharmaMar need to see what further data will be needed to convert their FDA authorization into a full approval following disappointing results in the ATLANTIS Phase III trial.